{"text_length": 2696, "summary": "WASHINGTON (AP) \u2014 The Food and Drug Administration has issued a long-awaited approval of Novavax\u2019s COVID-19 vaccine but with unusual restrictions. But late Friday, the FDA granted the company full approval for its vaccine for use only in adults 65 and older \u2013 or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19. Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial.", "timestamp": "2025-05-19 14:30:28"}